SeaLife’s shareholders decide on capital increase of T€ 800
22.07.2015
SeaLife’s shareholders decide on capital increase of T€ 800. To support the companies activities in pharmaceutical development and engagement in the registration of a new active substance in Biocidal/MedTech market, SeaLife’s shareholders to increase capital from shareholder funds in July 2015.
